Zihipp

Developer of drugs for obesity and diabetes treatment

placeLondon, England, United Kingdom calendar_todayFounded 2016 groups5 employees language zihipp.com

Registered entities

Innovation

1 patent family — focus: Human necessities; filing pace active. Cited 27 times.

YearFilings
20261

Investor mix

13 investors on record; lead investors include Mubadala.

Investor typeCountShare
Other / undisclosed13100%
Coming soon